United Therapeutics Chairperson and CEO Martine A. Rothblatt disposes of 9,500 common shares worth $4.69 million
UTHR•Reported stock transactions
United Therapeutics Chairperson and CEO Martine A. Rothblatt reported transactions in company common stock on Sep. 21, 2026.
- A family trust acquired 9,500 shares at $117.76 via stock option exercise.
- The same trust sold 9,500 shares in multiple trades at weighted-average prices from $492.97 to $496.62.
- Trust holdings ended at 324,443 shares of common stock.
- Stock options held by a family trust ended at 394,910 options, exercisable at $117.76, expiring Mar. 15, 2027.
